Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05304065 · ClinicalTrials.gov registry record · Phase 2
Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth
A Phase 2 study of Suicide and Self Harm, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 1,600
- Enrollment target
- 5
- Study locations
NCT05304065: Recruiting Phase 2 study of Suicide and Self Harm, sponsored by University of California, Los Angeles.
NCT05304065 is a Phase 2 study of Suicide and Self Harm that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 1,600 participants, below the 6,972-participant average among 92 other Suicide trials with a reported enrollment target (77% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05304065, a Phase 2 study of Suicide and Self Harm, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 1,600 participants
- Enrollment target
- 5
- Study locations
Study Summary
This randomized comparative effectiveness trial will compare two evidence-based approaches to emergency care for youth ages 13-24 who present to the Emergency Department (ED) with suicidal ideation or behavior. Outcomes will be monitored at baseline and at 3, 6 \& 12 month follow-up assessments.
Primary Outcome
suicide attempts fatal, nonfatal, and interrupted
Interventions
- BEHAVIORAL SAFETY-A within usual ED Care
- BEHAVIORAL Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts
Study Locations (5)
California
- Ronald Reagan Medical Center - Los Angeles
- Olive View UCLA Education and Research Center - Sylmar
North Carolina
- Duke University - Durham
Rhode Island
- Brown University - Providence
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2022-10-17 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 2 |
What NCT05304065 shows while recruiting
NCT05304065 is an interventional study that assigns participants to a tested intervention. Its 1,600 participants enrollment target places it among the larger protocols in the corpus, below the 6,972-participant average among 92 other Suicide trials with a reported enrollment target (77% lower).
The record links to 3 conditions, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which SAFETY-A within usual ED Care is the first listed.
NCT05304065 lists 5 locations in 4 states (California, North Carolina, Rhode Island).
Frequently Asked Questions
What is clinical trial NCT05304065 about?
NCT05304065 is a clinical study titled "Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth". This randomized comparative effectiveness trial will compare two evidence-based approaches to emergency care for youth ages 13-24 who present to the Emergency Department (ED) with suicidal ideation or behavior. Outcomes will be monitored at baseline and at 3, 6 \& 12 month follow-up assessments.
What is the current status of trial NCT05304065?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 1,600 participants. The study started on 2022-10-17. Estimated completion is 2026-12-31.
What conditions does trial NCT05304065 study?
This clinical trial studies the following conditions: Suicide, Self Harm, Suicidal.
What interventions are being tested in trial NCT05304065?
The interventions under investigation include: SAFETY-A within usual ED Care (BEHAVIORAL), Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts (BEHAVIORAL).
Who is sponsoring clinical trial NCT05304065?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05304065 being conducted?
This trial has 5 study locations across California, North Carolina, Rhode Island, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05304065's enrollment target sits among peer trials
1,600 9th of 92 higher than 84 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Suicide Risk Interventions
RECRUITING · Phase 2
-
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
RECRUITING · Phase 2
-
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
RECRUITING · Phase 2
-
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
RECRUITING · Phase 2
-
Developing an Intervention to Promote Lethal Means Safety in Suicidal Adolescents
COMPLETED · Phase 2
-
Evaluation of a School-Based Training Program for Suicide Prevention
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI